Dose Escalation Study to Investigate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BAY85-3934 in Subjects With Chronic Kidney Disease (CKD)
Clinical trial NCT01679587 · COMPLETED
Trial details
- NCT number
- NCT01679587
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2013-02-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.